JP Patent

JP3220180B2 — 薬剤含有タンパク質結合リポソーム

Assigned to Mitsubishi Chemical Corp · Expires 2001-10-22 · 25y expired

What this patent protects

Patent listed against givosiran-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP3220180B2
Jurisdiction
JP
Classification
—
Expires
2001-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Mitsubishi Chemical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.